Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 9/20 | 0.44 |
| ▸ | THRA | P10827 | 7/20 | 0.44 |
| ▸ | RORC | P51449 | 1/20 | 0.39 |
| ▸ | CSNK2A1 | P68400 | 3/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25950052 | 0.93 | THRB (0.39) | THRBTHRARORCCSNK2A1TTR | |
| SCHEMBL25338282 | 0.91 | THRB (0.49) | THRBTHRARORCCSNK2A1TTR | |
| SCHEMBL4215849 | 0.88 | THRB (0.49) | THRBTHRARORCCSNK2A1 | |
| SCHEMBL29970905 | 0.88 | THRB (0.49) | THRBTHRARORCCSNK2A1 | |
| SCHEMBL25950055 | 0.85 | THRB (0.46) | THRBTHRARORC | |
| SCHEMBL30286018 | 0.84 | THRB (0.44) | THRBTHRARORCMEN1ALDH1A1 | |
| SCHEMBL25949868 | 0.81 | THRB (0.38) | THRBTHRARORC | |
| SCHEMBL25950026 | 0.81 | THRB (0.43) | THRBTHRARORC | |
| SCHEMBL25950141 | 0.81 | THRB (0.43) | THRBTHRARORCTTR | |
| SCHEMBL30483268 | 0.81 | THRB (0.44) | THRBTHRARORCMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242471-A1 | THYROMIMETICS | AUTOBAHN THERAPEUTICS, INC. | 2023-08-03 | — | — | US | disclosed |
| EP-4168384-A1 | THYROMIMETICS | Autobahn Therapeutics, Inc. (US) | 2023-04-26 | — | — | EP | disclosed |
| CN-115916740-A | Thyromimetic agents | 速通医疗公司 | 2023-04-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242471-A1 | THYROMIMETICS | TPO, THOP1, THRB | THRB 3/4885THRA 6/4885RORC 630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.